Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis
David Zhang, Chad A. Newton, Binhan Wang, Gundula Povysil, Imre Noth, Fernando J. Martinez, Ganesh Raghu, David Goldstein, Christine Kim Garcia
Source: Eur Respir J, 60 (6) 2200577; 10.1183/13993003.00577-2022
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
David Zhang, Chad A. Newton, Binhan Wang, Gundula Povysil, Imre Noth, Fernando J. Martinez, Ganesh Raghu, David Goldstein, Christine Kim Garcia. Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis. Eur Respir J, 60 (6) 2200577; 10.1183/13993003.00577-2022
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|